Skip to main content
. 2018 Jun 12;13(6):e0198359. doi: 10.1371/journal.pone.0198359

Table 3. Proportions of various immune cell populations within the PPs following vehicle and oxaliplatin treatment.

Immune cell population Vehicle Oxaliplatin
Macrophages 1.3 ± 0.1 1.1 ± 0.3
Dendritic cells 2.9 ± 0.3 2.5 ± 0.7
Eosinophils: MHC-II+
MHC-II-
0.8 ± 0.2
0.6 ± 0.1
0.7 ± 0.01
0.7 ± 0.1
NK cells 1.7 ± 0.5 3.3 ± 1.1
γδ T cells 0.7 ± 0.01 0.8 ± 0.04
B cells 53.1 ± 1.4
45.5 ± 3.4
CD4+ T cells 56.0 ± 17.0 52.3 ± 14.8
CD8+ T cells 6.9 ± 1.8
10.1 ± 2.7
NKT cells 0.4 ± 0.1
0.6 ± 0.17